Psoriasis vulgaris (plaque psoriasis)
Exam relevance: in 27 of more than 50 board exam reports · rank 1
- Synonyms
- Schuppenflechte, psoriasis, plaque psoriasis
- Specialty
- Dermatology · Inflammatory skin diseases
- Images
- Clinical 10
- In the app
- 11 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (10)










Definition
Psoriatic Arthritis (PsA)
Inflammatory arthritis with frequent enthesitis/dactylitis. Typical: distal joint involvement, rest and night pain, start-up pain plus dactylitis ("sausage fingers"). Frequency: 6–40 % of psoriatic patients.
Classification
Main Forms
Plaque psoriasis (psoriasis vulgaris, 80–90%), guttate psoriasis, pustular psoriasis, palmoplantar psoriasis, inverse psoriasis, erythrodermic psoriasis, nail psoriasis, psoriatic arthritis.
Occurrence & epidemiology
Epidemiology — Comparative Figures for the Common Inflammatory Dermatoses
In Europe psoriasis affects about 2–3 % of the population — clearly more common than lichen planus and less common than atopic dermatitis in childhood.
| Disease | Prevalence | Comment |
|---|---|---|
| Psoriasis vulgaris | approx. 2–3 % of adults | two peaks of manifestation (see below) |
| Atopic dermatitis | children approx. 10–20 %, adults approx. 2–5 % | most common chronic skin disease of childhood |
| Lichen planus | approx. 0.5–1 % of adults | peak in middle adulthood |
| Psoriatic arthritis | 6–40 % of psoriasis patients | see section 5 |
- Two peaks of manifestation in psoriasis: type I (early onset) before the age of 40, strongly HLA-Cw6-associated, positive family history, usually more severe; type II (late onset) after the age of 40, less often familial, milder course.
- Men and women are affected with about equal frequency.
Aetiopathogenesis
Brief Etiopathogenesis
Immunology: Th17 inflammation with IL-17A/F, IL-23 and TNF-α. Genetics: predisposition via PSORS1–15 loci, especially HLA-Cw6.
Triggers: mechanical stimuli and infections (esp. streptococci). Pathology: accelerated epidermal regeneration (transit time ↓ from about 28 days to 3–5 days).
Genetics and Epidemiology
Type I: onset usually before age 40 (peak 2nd–3rd decade), strongly associated with HLA-C06:02, familial clustering, often more severe.
Type II: onset after age 40 (5th–6th decade), usually no HLA-C06:02, tends to be milder.
In Europe, 2–3 % prevalence; bimodal age distribution. Nail involvement in 40–50 %, psoriatic arthritis in ~33 %.
Systemic Associations & Comorbidities
Psoriasis is now considered a multisystem inflammatory disease with relevance beyond the skin. Associated: obesity & metabolic syndrome, cardiovascular disease, Crohn's and uveitis, depression and psychiatric disease, nicotine/alcohol dependence, liver fibrosis (MASLD).
Mutual exclusion: atopic eczema and allergic contact eczema less common in psoriasis.
Immunological Axes (Background)
Th1 axis (IL-2, IFN-γ, TNF-β) — intracellular pathogen defense, cellular autoimmunity. Diseases: MS, Hashimoto, T1DM, Crohn, TB.
Th2 axis (IL-4, IL-5, IL-9, IL-10, IL-13) — anti-parasitic; allergy, atopic eczema, asthma, allergic rhinitis, chronic spontaneous urticaria.
Th17 axis (IL-17A/F, IL-21, IL-22, IL-23) — barrier defense, neutrophilic inflammation. Diseases: psoriasis, Crohn, RA, hidradenitis suppurativa.
Genetic predisposition & IL-23/IL-17 dysregulation (> 80 %)
Susceptibility loci PSORS1–PSORS9, esp. HLA-C*06:02 (PSORS1), IL23R, IL12B → Th17 hypersensitivity, minor stimuli trigger sustained autoimmune activation.
Molecular mimicry after streptococci
Molecular mimicry after streptococcal infection — cross-reactivity between streptococcal M-proteins and keratin 17. Typical in guttate psoriasis, common first manifestation of Type I.
Koebner phenomenon (trauma-induced)
Scratching/tattoos/scars release DNA, HSPs and antimicrobial LL-37. Activation of dendritic cells via TLR9 → IL-23/IL-17 cascade. Seen in 30–50 % of patients.
Dysbiosis & microbial triggers
Dysbiosis & microbial triggers — gut + skin dysbiosis increasingly relevant.
Clinical features
Clinical Findings and Phenomena
Typical skin lesions are sharply demarcated, silvery-white scaling erythemato-squamous plaques.
- Koebner phenomenon: new psoriasis lesions on previously healthy skin after mechanical trauma (scratching, pressure, injury).
- Candle-wax phenomenon: scale can be scraped off like wax.
- Last membrane sign: further scraping reveals a thin intact epithelial layer.
- Auspitz phenomenon: removing this layer produces pinpoint bleeding from injured capillary loops (papillomatosis).
Histology
Histopathology
Hyper- and parakeratosis, absent stratum granulosum, acanthosis and papillomatosis. Elongated, thin rete ridges, club-shaped papillary bodies. Intracorneal (within the parakeratotic stratum corneum) Munro microabscesses. Diffuse lymphocytic infiltrate in the dermis with histiocytes, CD4+ lymphocytes and neutrophils.
Pustular form: dense accumulations of intact neutrophils spongiformly traversing the epidermis (Kogoj pustule).
Diagnosis
Dermoscopy
Dotted/glomerular vessels on erythematous background — uniform dot pattern vs. seborrheic dermatitis with branching vessels.
Basic Diagnostic Work-up (clinical + triggers)
- Diagnosis is primarily clinical, based on typical morphology and distribution. Biopsy only in unclear cases.
- Streptococcal serology (especially in guttate psoriasis): anti-streptolysin O, anti-DNase B, anti-hyaluronidase.
- Swabs from tonsils, anal rim, nasopharynx.
- Rheumatoid factor and anti-CCP to exclude rheumatoid arthritis.
- Mycological diagnostics to exclude dermatophytosis.
Central IL-23/IL-17 Axis
Core pathology: overactivation/dysregulation of the IL-23/IL-17 axis. Th17 cells secrete IL-17A/F and IL-22, driving keratinocyte proliferation and cytokine release (incl. IL-8). IL-8 is chemotactic for neutrophils → typical Munro microabscesses. The keratinocyte transit time shortens from about 28 days to only 3–5 days → scaling and thickening (hyperkeratosis).
Exam essentials
- Key point: sharply demarcated erythematous plaques with silvery-white scale, mainly on extensor surfaces (elbows, knees), scalp and sacral area.
- Psoriatic signs on scraping: candle-wax sign (scale comes off like wax), last-membrane sign and Auspitz sign (pinpoint bleeding after removal of the last membrane).
- Koebner phenomenon: new lesions at sites of mechanical trauma (isomorphic response).
- Think of nails and joints: nail changes are associated with psoriatic arthritis.
- Histology: acanthosis with regularly elongated rete ridges, parakeratosis, Munro microabscesses, thinned suprapapillary epidermis.
- Dermoscopy: regularly distributed dotted vessels on a light-red background with white scale.
- Severity: PASI (0–72), plus BSA and DLQI.
Differential diagnoses
Seborrhoeic dermatitis
Tinea corporis
Pityriasis rosea
Guttate psoriasis
Atopic dermatitis (atopic eczema)
Nummular eczema (discoid eczema)
Pityriasis versicolor (tinea versicolor)
Pityriasis rubra pilaris
Image credits for the thumbnails
- Seborrhoeic dermatitis: Roymishali, “Seborrhoeic dermatitis highres”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Tinea corporis: Corina G., “Tinea corporis”, Public Domain, via Wikimedia Commons · Public domain · Source
- Pityriasis rosea: Aceofhearts1968, “Pityriasis rosea-1”, Public Domain, via Wikimedia Commons · Public domain · Source
- Guttate psoriasis: Richard Keatinge, “Guttate psoriasis 66 year old male”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Atopic dermatitis (atopic eczema): Eisfelder, “Atopic dermatitis child”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Nummular eczema (discoid eczema): Ifnord, “Nummular dermatitits”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Pityriasis versicolor (tinea versicolor): Sarahrosenau on Flickr.com, “Tinea versicolor1”, CC BY-SA 2.0, via Wikimedia Commons · CC BY-SA 2.0 · Source
- Pityriasis rubra pilaris: Kelly McGauran, “Pityriasis Rubra Pilaris 10”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
Related conditions: how to tell them apart
- Nail psoriasis – pitting, oil spots, onycholysis – a pointer to joint involvement
- Guttate psoriasis – drop-like lesions, often after a streptococcal infection
- Psoriasis inversa – involvement of skin folds, usually without scaling
- Psoriatic arthritis – joint involvement in psoriasis
Treatment principles
- Treatment is based on severity: mild disease is treated topically, for example with glucocorticoids and vitamin D analogues.
- Moderate to severe disease or involvement of special sites requires phototherapy or systemic therapy with conventional agents or biologics.
- Comorbidities such as psoriatic arthritis and metabolic syndrome are taken into account; smoking cessation and weight loss support treatment success.
Guideline: AWMF guideline register (no. 013-001)
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Mentioned in
- Mycosis fungoides
- Porokeratosis
- ILVEN – inflammatory linear verrucous epidermal nevus
- Extramammary Paget disease
- Atopic dermatitis (atopic eczema)
- Erythema annulare centrifugum (EAC)
- Erythema migrans (Lyme disease)
- Filariasis
- Folliculitis decalvans
- Graft-versus-host disease (GvHD)
- Granuloma annulare
- Hand eczema
Keep learning: test yourself
Two questions from the DermaFuchs app on Psoriasis vulgaris (plaque psoriasis) – tap an answer.
Question 1 of 2
Which specific areas of the limbs are classic predilection sites for psoriasis vulgaris?
Answer
Correct: extensor surfaces. Psoriasis typically affects the extensor surfaces of the limbs, such as the elbows and knees, due to their susceptibility to mechanical stress (Koebner phenomenon).
Question 2 of 2
What are the characteristic histological features of the epidermis in psoriasis?
Answer
Correct: hyperproliferation and parakeratosis. Psoriasis is characterized by epidermal hyperproliferation (acanthosis) and parakeratosis (retained nuclei in the stratum corneum) due to rapid keratinocyte turnover.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.